← Back to Search

Nonsteroidal Anti-inflammatory Drug

Aspirin for Deep Vein Thrombosis (PARTUM Trial)

Q: What is the ceiling of enrollees for this clinical research?

Affirmative. The trial is currently recruiting, as evidenced by the information found on clinicaltrials.gov. This research was first posted October 7th 2020 and most recently updated December 1st 2022; it seeks to include 384 individuals from a single site in its study population.

Q: Has a similar experiment ever been conducted before?

Since 2005, Aspirin has been subject to extensive clinical research. Abbott sponsored the inaugural study in that year which had a total of 15480 participants. Afterward, it was granted its Phase 4 drug approval and now there are 167 active trials for this medication spread across 57 nations with 1398 sites involved.

Q: In what clinical scenarios is Aspirin typically prescribed?

Aspirin is commonly deployed to treat percutaneous coronary intervention (PCI) and can also provide relief from ailments such as dental procedures, inflammation, and neck <a href="https://www.withpower.com/clinical-trials/pain">pain</a>.

Q: Is there an open enrollment for this clinical investigation?

Correct. Information hosted on clinicaltrials.gov indicates that this medical research study, which was initially posted on October 7th 2020, is actively seeking participants. Specifically, 384 people need to be recruited from one site for the trial's completion.

Phase < 1

Waitlist Available

Led By Marc Rodger, MD

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

PARTUM Trial Summary

This trial is testing whether aspirin can prevent blood clots in pregnant women.

Eligible Conditions

Deep Vein Thrombosis (DVT)
Aspirin
Postpartum

PARTUM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Recruitment Rate

Secondary outcome measures

Bleeding Event Rate

Consent Rate

Study Drug Compliance

+3 more

PARTUM Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: AspirinActive Control1 Intervention

Aspirin 81 mg daily for six weeks post-randomization (postpartum)

Group II: PlaceboPlacebo Group1 Intervention

Placebo daily for six weeks post-randomization (postpartum)

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor

792 Previous Clinical Trials

868,897 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,344 Previous Clinical Trials

26,453,160 Total Patients Enrolled

11 Trials studying Deep Vein Thrombosis

9,434 Patients Enrolled for Deep Vein Thrombosis

Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR) NetworkNETWORK

10 Previous Clinical Trials

17,206 Total Patients Enrolled

1 Trials studying Deep Vein Thrombosis

1,500 Patients Enrolled for Deep Vein Thrombosis

Media Library

Aspirin 81 mg (Nonsteroidal Anti-inflammatory Drug) Clinical Trial Eligibility Overview. Trial Name: NCT04153760 — Phase < 1

Deep Vein Thrombosis Research Study Groups: Aspirin, Placebo

Deep Vein Thrombosis Clinical Trial 2023: Aspirin 81 mg Highlights & Side Effects. Trial Name: NCT04153760 — Phase < 1

Aspirin 81 mg (Nonsteroidal Anti-inflammatory Drug) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04153760 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the ceiling of enrollees for this clinical research?

"Affirmative. The trial is currently recruiting, as evidenced by the information found on clinicaltrials.gov. This research was first posted October 7th 2020 and most recently updated December 1st 2022; it seeks to include 384 individuals from a single site in its study population."

Answered by AI

Has a similar experiment ever been conducted before?

"Since 2005, Aspirin has been subject to extensive clinical research. Abbott sponsored the inaugural study in that year which had a total of 15480 participants. Afterward, it was granted its Phase 4 drug approval and now there are 167 active trials for this medication spread across 57 nations with 1398 sites involved."

Answered by AI

In what clinical scenarios is Aspirin typically prescribed?

"Aspirin is commonly deployed to treat percutaneous coronary intervention (PCI) and can also provide relief from ailments such as dental procedures, inflammation, and neck pain."

Answered by AI

Is there an open enrollment for this clinical investigation?

"Correct. Information hosted on clinicaltrials.gov indicates that this medical research study, which was initially posted on October 7th 2020, is actively seeking participants. Specifically, 384 people need to be recruited from one site for the trial's completion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

2020. "Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04153760.